Liposomal formulation of curcumin attenuates seizures in different experimental models of epilepsy in mice

Fundam Clin Pharmacol. 2013 Apr;27(2):169-72. doi: 10.1111/j.1472-8206.2011.01002.x. Epub 2011 Nov 2.

Abstract

Contemporary research indicates promising anticonvulsant effect of curcumin. However, its poor oral bioavailability is a major hindrance toward its pharmacological action. Thus, this study was carried out to evaluate the acute effect of liposome-entrapped curcumin on increasing current electroshock seizures (ICES) test, pentylenetetrazole (PTZ)-induced seizures, and status epilepticus in mice. Liposome-entrapped curcumin in doses 25 and 50 mg/kg demonstrated significant increase in seizure threshold current and latency to myoclonic and generalized seizures in ICES test and PTZ-induced seizures, respectively. Similarly, liposomal-entrapped curcumin also increased the latency to the onset and decreased the duration of seizures during status epilepticus in mice. To conclude, liposomal-entrapped curcumin possesses anticonvulsant activity against status epilepticus in mice.

MeSH terms

  • Animals
  • Anticonvulsants / administration & dosage
  • Anticonvulsants / chemistry
  • Biological Availability
  • Chemistry, Pharmaceutical / methods
  • Curcumin / administration & dosage*
  • Curcumin / chemistry
  • Curcumin / pharmacokinetics
  • Disease Models, Animal
  • Drug Interactions
  • Epilepsy / chemically induced
  • Epilepsy / drug therapy*
  • Epilepsy / metabolism
  • Liposomes / administration & dosage*
  • Liposomes / chemistry
  • Liposomes / pharmacokinetics
  • Male
  • Mice
  • Pentylenetetrazole
  • Seizures / chemically induced
  • Seizures / drug therapy*
  • Seizures / metabolism

Substances

  • Anticonvulsants
  • Liposomes
  • Curcumin
  • Pentylenetetrazole